{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:12:13Z","timestamp":1777331533662,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.iac.2004.03.001","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T14:53:30Z","timestamp":1113836010000},"page":"491-505","source":"Crossref","is-referenced-by-count":86,"title":["Aspirin and NSAID sensitivity"],"prefix":"10.1016","volume":"24","author":[{"given":"Donald D","family":"Stevenson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1A","key":"10.1016\/j.iac.2004.03.001_BIB1","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1016\/S0002-9343(00)00627-6","article-title":"Nonsteroidal anti-inflammatory drug prescribing: past, present and future","volume":"110","author":"Jones","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.iac.2004.03.001_BIB2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.7326\/0003-4819-66-3-568","article-title":"Bronchial asthma induced by indomethacin","volume":"66","author":"Vanselow","year":"1967","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.iac.2004.03.001_BIB3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(98)12154-2","article-title":"COX-2 inhibitors","volume":"353","author":"Hawley","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.iac.2004.03.001_BIB4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1081-1206(10)62221-1","article-title":"Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes","volume":"87","author":"Stevenson","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2004.03.001_BIB5","series-title":"Middleton: allergy principles and practice","first-page":"1695","article-title":"Sensitivity to aspirin and NSAIDs","author":"Stevenson","year":"2003"},{"key":"10.1016\/j.iac.2004.03.001_BIB6","series-title":"Upper and lower respiratory disease","first-page":"335","article-title":"Aspirin and NSAID sensitivity","author":"Stevenson","year":"2003"},{"key":"10.1016\/j.iac.2004.03.001_BIB7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1385\/CRIAI:24:2:113","article-title":"Natural history and clinical features of aspirin-exacerbated respiratory disease","volume":"24","author":"Fahrenholz","year":"2003","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.iac.2004.03.001_BIB8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)62084-4","article-title":"The natural history and clinical characteristics of aspirin exacerbated respiratory disease","volume":"89","author":"Berges-Gimeno","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2004.03.001_BIB9","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1067\/mai.2002.123024","article-title":"Sinusitis and asthma: entering the realm of evidence-based medicine","volume":"109","author":"Borish","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2004.03.001_BIB10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1385\/CRIAI:24:2:159","article-title":"Aspirin desensitization in patients with AERD","volume":"24","author":"Stevenson","year":"2003","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.iac.2004.03.001_BIB11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/00325481.1985.11699116","article-title":"Aspirin sensitivity in asthmatics: when may this drug be safe?","volume":"78","author":"Stevenson","year":"1985","journal-title":"Postgrad Med"},{"key":"10.1016\/j.iac.2004.03.001_BIB12","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1067\/mai.2003.1487","article-title":"Aspirin-induced asthma: advances in pathogenesis, diagnosis and management","volume":"111","author":"Szczeklik","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2004.03.001_BIB13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1385\/CRIAI:24:2:125","article-title":"Cutaneous reactions to aspirin and NSAIDs","volume":"24","author":"Sanchez-Borges","year":"2003","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.iac.2004.03.001_BIB14","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bmj.4.5574.262","article-title":"Effect of salicylates in urticaria","volume":"4","author":"Moore-Robinson","year":"1967","journal-title":"BMJ"},{"key":"10.1016\/j.iac.2004.03.001_BIB15","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2133.1960.tb13817.x","article-title":"Effect of aspirin in chronic urticaria","volume":"72","author":"Warren","year":"1960","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.iac.2004.03.001_BIB16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0091-6749(62)80451-5","article-title":"Aspirin in chronic urticaria and\/or angioedema: studies of sensitivity and desensitization","volume":"69","author":"Mathison","year":"1982","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2004.03.001_BIB17","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/archderm.139.12.1577","article-title":"Safety of COX-2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to NSAIDs","volume":"139","author":"Zembowics","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.iac.2004.03.001_BIB18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1385\/CRIAI:24:2:137","article-title":"Anaphylactic and anaphylactoid reactions to aspirin and other NSAIDs","volume":"24","author":"Berkes","year":"2003","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.iac.2004.03.001_BIB19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2222.1976.tb01934.x","article-title":"Oral aspirin challenges in asthmatic patients: a study of plasma histamine","volume":"6","author":"Stevenson","year":"1976","journal-title":"Clin Allergy"},{"key":"10.1016\/j.iac.2004.03.001_BIB20","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/0091-6749(91)90238-J","article-title":"Tryptase and histamine release during aspirin-induced respiratory reactions","volume":"88","author":"Bosso","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2004.03.001_BIB21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1183\/09031936.93.06030391","article-title":"Cysteinyl leukotriene overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma","volume":"6","author":"Sladek","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.iac.2004.03.001_BIB22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1385\/CRIAI:24:2:149","article-title":"Cross-reacting drugs and chemicals","volume":"24","author":"Woessner","year":"2003","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.iac.2004.03.001_BIB23","series-title":"Allergy: principles and practice","first-page":"1079","article-title":"Anaphylaxis and anaphylactoid reactions","author":"Liberman","year":"1998"},{"key":"10.1016\/j.iac.2004.03.001_BIB24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1159\/000230534","article-title":"Immunologic effects of aspirin anhydride, a contaminant of commercial acetylsalicylic acid preparations","volume":"41","author":"DeWeck","year":"1971","journal-title":"Int Arch Allergy"},{"key":"10.1016\/j.iac.2004.03.001_BIB25","first-page":"72","article-title":"Sensitivity to aspirin: a new serologic diagnostic method","volume":"3","author":"Daxun","year":"1993","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.iac.2004.03.001_BIB26","first-page":"295","article-title":"Angioedema and IgE antibodies to aspirin: a case report","volume":"62","author":"Blanca","year":"1989","journal-title":"Ann Allergy"},{"issue":"Suppl","key":"10.1016\/j.iac.2004.03.001_BIB27","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2165\/00003495-198600324-00011","article-title":"Analgesics, allergy and asthma","volume":"4","author":"Szczeklik","year":"1986","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.iac.2004.03.001_BIB28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1067\/mai.2001.113241","article-title":"Selective severe anaphylactic reaction due to ketorolac tromethamine without nonsteroidal anti-inflammatory drug intolerance","volume":"107","author":"Scala","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2004.03.001_BIB29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1081-1206(10)62748-2","article-title":"Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity","volume":"84","author":"Sanchez-Borges","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.iac.2004.03.001_BIB30","first-page":"323","article-title":"Anaphylactoid reactions to tolmetin and zomepirac","volume":"50","author":"Rake","year":"1983","journal-title":"Ann Allergy"},{"key":"10.1016\/j.iac.2004.03.001_BIB31","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0196-0644(84)80013-X","article-title":"Anaphylactic reaction associated with sulindac","volume":"13","author":"Jett","year":"1984","journal-title":"Ann Emerg Med"},{"issue":"Suppl","key":"10.1016\/j.iac.2004.03.001_BIB32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2165\/00003495-199300461-00065","article-title":"Oral challenges with alternative NSAIDs and paracetamol in patients intolerant to these agents","volume":"46","author":"Ispano","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.iac.2004.03.001_BIB33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1081-1206(10)62226-0","article-title":"Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions","volume":"87","author":"Sanchez-Borges","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.iac.2004.03.001_BIB34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1081-1206(10)63184-5","article-title":"Anaphylactoid reactions due to nonsteroidal anti-inflammatory drugs: clinical and cross-reactivity studies","volume":"78","author":"Quiralte","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2004.03.001_BIB35","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1001\/jama.268.20.2844","article-title":"Allergic reactions to drugs and biological agents","volume":"268","author":"Anderson","year":"1992","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.iac.2004.03.001_BIB36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1081-1206(10)62318-6","article-title":"Clinical features of acute anaphylaxis in patients admitted to a university hospital: an 11-year retrospective review (1985\u20131996)","volume":"87","author":"Cianferoni","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2004.03.001_BIB37","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/archinte.1995.00430160077008","article-title":"Anaphylaxis: a review of 266 cases","volume":"155","author":"Kemp","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.iac.2004.03.001_BIB38","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1365-2222.2003.01671.x","article-title":"Anaphylaxis: risk factors for recurrence","volume":"33","author":"Mullins","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2004.03.001_BIB39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0091-6749(89)90174-7","article-title":"Cross-sensitivity with acetaminophen in aspirin-sensitive asthmatics","volume":"84","author":"Settipane","year":"1989","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2004.03.001_BIB40","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0091-6749(95)70290-3","article-title":"Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects","volume":"96","author":"Settipane","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2004.03.001_BIB41","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0091-6749(05)80179-4","article-title":"Disalcid cross-sensitivity in aspirin-sensitive asthmatics","volume":"86","author":"Stevenson","year":"1990","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.iac.2004.03.001_BIB42","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2222.1992.tb02827.x","article-title":"Paracetamol anaphylaxis","volume":"22","author":"Leung","year":"1992","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"10.1016\/j.iac.2004.03.001_BIB43","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1081-1206(10)63352-2","article-title":"Acetaminophen anaphylaxis with aspirin and sodium salicylate sensitivity: a case report","volume":"77","author":"Schwarz","year":"1996","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2004.03.001_BIB44","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1081-1206(10)62231-4","article-title":"A report of a rare immediate reaction after ingestion of acetaminophen","volume":"87","author":"Grant","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2004.03.001_BIB45","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/bmj.291.6500.938","article-title":"Acute hypersensitivity reactions to paracetamol","volume":"291","author":"Stricker","year":"1985","journal-title":"BMJ"},{"key":"10.1016\/j.iac.2004.03.001_BIB46","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1081-1206(10)62412-X","article-title":"Tolerability of meloxicam in patients with histories of adverse reactions to NSAIDs","volume":"84","author":"Quartino","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2004.03.001_BIB47","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S1081-1206(10)63166-3","article-title":"Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders","volume":"82","author":"Asero","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2004.03.001_BIB48","first-page":"715","article-title":"Tolerance of meloxicam in aspirin-sensitive asthmatics","volume":"157","author":"Vaghi","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.iac.2004.03.001_BIB49","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1365-2222.2001.01075.x","article-title":"Safety of a specific COX-2 inhibitor in aspirin-induced asthma","volume":"31","author":"Szczeklik","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2004.03.001_BIB50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1067\/mai.2001.116290","article-title":"Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive asthmatic patients","volume":"108","author":"Stevenson","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2004.03.001_BIB51","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1378\/chest.121.6.1812","article-title":"Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma","volume":"121","author":"Martin-Garcia","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.iac.2004.03.001_BIB52","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1067\/mai.2000.110926","article-title":"Selective cyclo-oxygenase 2 inhibitor in patients with aspirin-induced asthma","volume":"106","author":"Yoshida","year":"2000","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.iac.2004.03.001_BIB53","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/art.10426","article-title":"The safety of celecoxib in aspirin exacerbated respiratory disease","volume":"46","author":"Woessner","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.iac.2004.03.001_BIB54","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1067\/mai.2003.1450","article-title":"Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgesic drug celecoxib","volume":"111","author":"Gyllfors","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.iac.2004.03.001_BIB55","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1034\/j.1398-9995.2001.00300.x","article-title":"Tolerability of rofecoxib","volume":"56","author":"Asero","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2004.03.001_BIB56","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1034\/j.1398-9995.2001.00206.x","article-title":"Rofecoxib: safe in NSAID intolerant patients","volume":"56","author":"Berges-Gimeno","year":"2001","journal-title":"Eur J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2004.03.001_BIB57","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1365-2222.2002.01260.x","article-title":"Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and\/or non-steroidal anti-inflammatory drugs","volume":"32","author":"Pacor","year":"2002","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.iac.2004.03.001_BIB58","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1081-1206(10)62017-0","article-title":"Tolerability of rofecoxib in patients with cutaneous adverse reactions to NSAIDs","volume":"88","author":"Nettis","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2004.03.001_BIB59","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1081-1206(10)61912-6","article-title":"Safety of selective cyclooxgenase-2 inhibitor rofecoxib in patients with NSAID-induced cutaneous reactions","volume":"89","author":"Quiralte","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2004.03.001_BIB60","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1034\/j.1398-9995.2002.23836_7.x","article-title":"Celecoxib: safe in NSAID intolerance","volume":"57","author":"Garcia-Rodriguez","year":"2002","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.iac.2004.03.001_BIB61","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1081-1206(10)62327-7","article-title":"Anaphylaxis to celecoxib","volume":"87","author":"Levy","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"25","key":"10.1016\/j.iac.2004.03.001_BIB62","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJM200112203452518","article-title":"Anaphylactoid reaction to a cyclooxygenase-2 inhibitor in a patient who had a reaction to a cyclooxygenase-1 inhibitor","volume":"345","author":"Schellenberg","year":"2001","journal-title":"N Engl J Med"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985610400027X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985610400027X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T23:36:55Z","timestamp":1706139415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985610400027X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S088985610400027X"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2004.03.001","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}